Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
14,22 USD | -1,25% | +2,89% | -5,20% |
Attività
Numero di dipendenti: 200
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
RTGel Reverse-Thermal Hydrogel
100,0
%
| 64 | 100,0 % | 83 | 100,0 % | +28,52% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 64 | 100,0 % | 83 | 100,0 % | +28,52% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 62 | 03/01/19 | |
Dong Kim
DFI | Director of Finance/CFO | 47 | 01/08/21 |
Jason Smith
CMP | Compliance Officer | 52 | 09/09/20 |
Marina Konorty
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/11 |
Moran Mieron
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Mark Schoenberg
CTO | Chief Tech/Sci/R&D Officer | 66 | 09/02/16 |
Investor Relations Contact | - | 01/01/22 | |
Polly Murphy
PRN | Corporate Officer/Principal | 59 | 09/09/20 |
Jeff Bova
PRN | Corporate Officer/Principal | - | 01/01/17 |
James Ottinger
LAW | General Counsel | - | 01/10/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Arie Belldegrun
CHM | Chairman | 74 | 01/10/12 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 01/10/17 |
Fred Cohen
BRD | Director/Board Member | 67 | 16/05/17 |
Stuart Holden
BRD | Director/Board Member | 82 | 01/12/15 |
Chief Executive Officer | 62 | 03/01/19 | |
James Robinson
BRD | Director/Board Member | 54 | 25/07/23 |
Daniel Wildman
BRD | Director/Board Member | 68 | 08/11/22 |
Leana Wen
BRD | Director/Board Member | 41 | 12/09/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 36 130 121 | 30 249 041 ( 83,72 %) | 0 | 83,72 % |
Coordinate società
UroGen Pharma Ltd.
400 Alexander Park Drive 4th floor
08540, Princeton
+(646) 768-9780
http://www.urogen.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-5,20% | 491 Mln | |
-1,65% | 104 Mrd | |
+6,75% | 97,47 Mrd | |
+5,71% | 22,25 Mrd | |
-12,60% | 21,68 Mrd | |
-9,70% | 18,2 Mrd | |
-39,98% | 17,02 Mrd | |
-10,17% | 16,36 Mrd | |
+6,12% | 14,39 Mrd | |
+35,47% | 12,37 Mrd |
- Borsa valori
- Azioni
- Azione URGN
- Società UroGen Pharma Ltd.